Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05365360 · ClinicalTrials.gov registry record · NA
Sham LaserCap vs. LaserCap SD vs. LaserCap HD+
A NA study of Androgenetic Alopecia, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05365360 is a NA study of Androgenetic Alopecia that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 50 participants, below the 162-participant average among 16 other Androgenetic Alopecia trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05365360, a NA study of Androgenetic Alopecia, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Androgenetic alopecia (AGA) is a prevalent disease, occurring in 80% of Caucasian men and 50% of Caucasian women by age 701. Treatments for AGA are limited, and presently the only FDA-approved medications for AGA are topical minoxidil and oral finasteride1. In addition to medical therapies, FDA-cleared medical devices are now utilized for the treatment of AGA as of 20072. These devices, termed low level laser therapy (LLLT), come in multiple forms including combs, helmets and sports cap wearable devices2. These home-use, wearable devices utilize the \~650 nm wavelength laser light to stimulate the hair follicle mitochondria and thereby promote hair growth, a process termed "photobiomodulation"3. Recent meta-analyses investigating photobiomodulation and LLLT for AGA have noted an increase in fluence or energy delivered per cm is associated with increased hair density3. However, randomized control trials (RCT) with direct comparison of LLLT devices of different fluences has yet to be performed. Accordingly, in the present study we aim to investigate if increasing fluence in LLLT devices is associated with increased hair density by comparing sham LaserCap to LaserCap SD (1.15 J/cm2, low fluence) and LaserCap HD+ (3.93 J/cm2, high fluence) in RCT.
Conditions Studied
Interventions
- DEVICE LaserCap SD
- DEVICE Sham LaserCap
- DEVICE LaserCap HD+
Study Locations (1)
Arizona
- Banner University Dermatology - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05365360
The ClinicalTrials.gov registry entry for NCT05365360 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 162-participant average among 16 other Androgenetic Alopecia trials with a reported enrollment target (69% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Androgenetic Alopecia appearing as the primary indexed condition, and to 3 interventions - of which LaserCap SD is the first listed.
NCT05365360 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05365360 about?
NCT05365360 is a clinical study titled "Sham LaserCap vs. LaserCap SD vs. LaserCap HD+". Androgenetic alopecia (AGA) is a prevalent disease, occurring in 80% of Caucasian men and 50% of Caucasian women by age 701. Treatments for AGA are limited, and presently the only FDA-approved medications for AGA are topical minoxidil and oral finasteride1. In addition to medical therapies, FDA-cle...
What is the current status of trial NCT05365360?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-06-01. Estimated completion is 2025-05.
What conditions does trial NCT05365360 study?
This clinical trial studies the following conditions: Androgenetic Alopecia.
What interventions are being tested in trial NCT05365360?
The interventions under investigation include: LaserCap SD (DEVICE), Sham LaserCap (DEVICE), LaserCap HD+ (DEVICE).
Who is sponsoring clinical trial NCT05365360?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05365360 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Androgenetic Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
RECRUITING · NA
-
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
COMPLETED · NA
-
Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss
COMPLETED · NA
-
Computer-Assisted Versus Manual Hair Harvest Comparative Study
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
-
A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.